Clinical Trial Update: Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ARNI to other oral vasodilator therapies in patients with cardiogenic shock was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• ARNI

Snippet

Sponsor: The Cleveland Clinic | Conditions: Cardiogenic Shock | Phase 4 | Status: WITHDRAWN